Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 23 2014
Print RSS Feed

Breaking News

February 19, 2014
13 prequalified companies will participate in program to enhance security of imported drugs  Read More »
Gil Roth
February 18, 2014
Capital investments reflect ongoing commitment to contract services  Read More »
Gil Roth
February 18, 2014
$25 bil. purchase will create $15 bil. company  Read More »
Gil Roth
February 18, 2014
Expands ADC characterization  Read More »
Gil Roth
February 18, 2014
Orantes to lead U.S. operations  Read More »
Gil Roth
February 18, 2014
Expands cancer immunotherapy, adds immune-modulating targets and technology  Read More »
Gil Roth
February 18, 2014
Will provide mammalian, microbial services to clinical-stage company  Read More »
Kristin Brooks
February 14, 2014
Attains growth in medical and specialty commercial markets  Read More »
Kristin Brooks
February 14, 2014
Catalent to provide commercial supply from Kansas City site  Read More »
Kristin Brooks
February 14, 2014
Hoffman brings more than 25 years of experience  Read More »
Kristin Brooks
February 14, 2014
Invests $200 million in SUB manufacturing infrastructure  Read More »
Kristin Brooks
February 14, 2014
Will discontinue Phase II study in colorectal cancer  Read More »
Kristin Brooks
February 14, 2014
To provide preclinical drug development through to Phase I - IV trials  Read More »
Kristin Brooks
February 13, 2014
Revenues up 8% in the quarter   Read More »
Kristin Brooks
February 13, 2014
Revenues up 7% in the quarter driven by Culex sales  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On